Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALStandard

CATAPRES-TTS-1

CLONIDINE

Standard Dose
0.1MG/24HR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CATAPRES-TTS-1 is listed in Drugs@FDA under application 018891 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CLONIDINE Form and strength SYSTEM;TRANSDERMAL - 0.1MG/24HR Sponsor LAVIPHARM Submission history Latest submission status date: 2023-02-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview CATAPRES-TTS-1 is listed in Drugs@FDA under application 018891 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLONIDINE Form and strength SYSTEM;TRANSDERMAL - 0.1MG/24HR Sponsor LAVIPHARM Submission history Latest submission status date: 2023-02-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.